Nivolumab/pembrolizumabVarious toxicities: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1863卷 / 1期

关键词：

D O I：

10.1007/s40278-021-98882-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：278 / 278

相关论文

共 50 条

[41] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 18 case reports
Reactions Weekly, 2023, 1957 (1) : 315 - 315
[42] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 29 case reports
Reactions Weekly, 2021, 1859 (1) : 201 - 201
[43] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1929 (1) : 360 - 360
[44] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1751 (1) : 221 - 221
[45] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 14 case reports
Reactions Weekly, 2022, 1907 (1) : 271 - 271
[46] Ipilimumab/nivolumab/pembrolizumabVarious toxicities : 5 case reports
Reactions Weekly, 2024, 2019 (1) : 231 - 231
[47] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 38 case reports
Reactions Weekly, 2019, 1734 (1) : 295 - 295
[48] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1715 (1) : 147 - 147
[49] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1813 (1) : 140 - 140
[50] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1891 (1) : 175 - 175

← 1 2 3 4 5 →